IMI-EU funding to accelerate Advanced Therapy Medicinal Products

iBET participates in ARDAT – Accelerating Research and Innovation for Advanced Therapies – a project which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs). This project is supported by Europe’s Innovative Medicines Initiative (IMI) with €25.5 million.

ATMPs have unprecedented potential to significantly improve patients’ life quality. ATMP research is growing exponentially, it is expected that up to 10 to 20 new drug applications submitted per year to the FDA by 2025 are ATMPs. As an emerging field…

iBET participates in ARDAT